About ocean biomedical inc - OCEA
Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.
OCEA At a Glance
Ocean Biomedical, Inc.
55 Claverick Street
Providence, Rhode Island 02903
| Phone | 1-401-444-7375 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Major | Net Income | -9,480,000.00 | |
| Sector | Health Technology | Employees | 7 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
OCEA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -8.237 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.521 |
OCEA Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -1,354,285.714 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
OCEA Liquidity
| Current Ratio | 0.024 |
| Quick Ratio | 0.024 |
| Cash Ratio | 0.007 |
OCEA Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -296.111 |
| Return on Equity | N/A |
| Return on Total Capital | 11.658 |
| Return on Invested Capital | N/A |
OCEA Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -20.045 |
| Total Debt to Total Assets | 1,807.095 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |